The forecasted sales of hypnotic and sedative medicine in Australia show a decreasing trend from 2024 to 2028. In 2023, the sales stood at 15.2 million US Dollars PPP. The year-on-year variations from 2024 to 2028 are as follows:
- 2024: -1.3%
- 2025: -2.0%
- 2026: -2.7%
- 2027: -1.4%
- 2028: -1.4%
The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is -1.76%, indicating a slow but steady decline in sales over the five-year period. This trend suggests a decreasing demand or possible increased regulation impacting sales volumes.
Future trends to watch for in this category include developments in alternative treatments, changes in prescription regulations, and advancements in mental health care approaches which might further affect sales dynamics.
